Endovascular treatment of a hepatic artery aneurysm causing chronic abdominal pain; a case report
Journal Title: Annals of Hepatology - Year 2010, Vol 9, Issue 1
Abstract
Background. Aneurysms of the visceral arteries are rare but potentially lethal lesions. We describe a case of a successful endovascular exclusion of a hepatic artery aneurysm in a patient that suffered from chronic abdominal pain. Case Report. A 68-year old man presented with chronic abdominal pain that had existed for 10 months. A diagnostic contrast-enhanced CT scan showed an 18 mm atherosclerotic aneurysm of the hepatic artery. When other pathology was excluded the aneurysm was excluded using an ePTFE-covered nitinol stentgraft. Post-deployment angiograms showed a complete exclusion of the aneurysm. The abdominal complaints immediately resolved. After a follow-up period of 18 months patient had a patent endograft and remained free of symptoms. Conclusions. Small hepatic artery aneurysms may cause chronic recurrent abdominal pain and can be safely excluded using a covered stentgraft.
Authors and Affiliations
Gabrielle de Ruiter-Derksen, Rutger Bruijnen, Frank Joosten, Michel Reijnen
Keywords
Related Articles
- EP ID EP77921
- DOI -
- Views 152
- Downloads 0
Antiproliferative Effects of Epigenetic Modifier Drugs Through E-cadherin Up-regulation in Liver Cancer Cell Lines
Introduction. Epigenetic alterations play an essential role in cancer onset and progression, thus studies of drugs targeting the epigenetic machinery are a principal concern for cancer treatment. Here, we evaluated the p...
Treatment of nonalcoholic steatohepatitis with probiotics. A proof-of-concept study
[b]Background[/b]. Probiotics have profound effect on nonalcoholic steatohepatitis (NASH) in animal models. We aimed to test the hypothesis that probiotics treatment was superior to usual care in reducing liver fat in NA...
Hepatoportal sclerosis related to the use of herbals and nutritional supplements. Causality or coincidence?
Introduction and aim. Non-cirrhotic idiopathic portal hypertension (NCIPH), also known as hepatoportal sclerosis (HPS) is a disease of uncertain etiology. However, various pathophysiological mechanisms has been postulat...
Diagnostic performance of controlled attenuation parameter for predicting steatosis grade in chronic hepatitis B
Background & aims. A novel controlled attenuation parameter (CAP) using the signals acquired by the FibroScan® has been developed as a method for evaluating steatosis. The aim of this study is to assess the p...
Bile salt export pump deficiency disease: two novel, late onset, ABCB11 mutations identified by next generation sequencing
Progressive familial intrahepatic cholestasis (PFIC) is a heterogeneous group of autosomal recessive cholestatic diseases of childhood and represents the main indication for liver transplantation at this age; PFIC2 invo...